BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29729471)

  • 1. Meningioma and Bone Hyperostosis: Expression of Bone Stimulating Factors and Review of the Literature.
    Di Cristofori A; Del Bene M; Locatelli M; Boggio F; Ercoli G; Ferrero S; Del Gobbo A
    World Neurosurg; 2018 Jul; 115():e774-e781. PubMed ID: 29729471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does bony hyperostosis in intracranial meningioma signify tumor invasion? A radio-pathologic study.
    Goyal N; Kakkar A; Sarkar C; Agrawal D
    Neurol India; 2012; 60(1):50-4. PubMed ID: 22406780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Putting Back Hyperostotic Bone Flap in Meningioma Surgery Cause Tumor Recurrence? An Observational Prospective Study.
    Lau BL; Che Othman MI; Fathil MFMD; Liew DNS; Lim SS; Bujang MA; Wong ASH
    World Neurosurg; 2019 Jul; 127():e497-e502. PubMed ID: 30926555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway.
    Johnson MD; O'Connell MJ; Vito F; Pilcher W
    J Neuropathol Exp Neurol; 2009 Nov; 68(11):1177-83. PubMed ID: 19816200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Convexity hyperostotic meningioma en plaque: a systematic review].
    Efremov KV; Kozlov AV; Tanyashin SV; Kuldashev KA; Zabolotny RV
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):103-108. PubMed ID: 38334737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.
    Jin L; Youngblood MW; Gupte TP; Vetsa S; Nadar A; Barak T; Yalcin K; Aguilera SM; Mishra-Gorur K; Blondin NA; Gorelick E; Omay SB; Pointdujour-Lim R; Judson BL; Alperovich M; Aboian MS; McGuone D; Gunel M; Erson-Omay Z; Fulbright RK; Moliterno J
    J Neurooncol; 2021 Sep; 154(2):237-246. PubMed ID: 34350560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating Hyperostotic Temporal Bone Meningioma En Plaque and Fibrous Dysplasia on Computed Tomographic Imaging.
    Shapiro S; Cassis A
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):316-317. PubMed ID: 27585392
    [No Abstract]   [Full Text] [Related]  

  • 8. Extent of Hyperostotic Bone Resection in Convexity Meningioma to Achieve Pathologically Free Margins.
    Fathalla H; Tawab MGA; El-Fiki A
    J Korean Neurosurg Soc; 2020 Nov; 63(6):821-826. PubMed ID: 32750757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thallium-201 single photon emission computed tomography imaging of meningioma cells in hyperostosis.
    Mori K; Cho K; Suda K; Ishimaru S; Maeda M
    Neurol Med Chir (Tokyo); 1997 Aug; 37(8):594-9. PubMed ID: 9301194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.
    Pei J; Jung S; Jin SG; Moon KS; Wen M; Li SY; Jang WY; Ryu HH; Lee KH; Kim IY; Jung TY
    Acta Neurochir (Wien); 2012 Apr; 154(4):611-20; discussion 620. PubMed ID: 22327326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperostosis in meningiomas: MR findings in patients with recurrent meningioma of the sphenoid wings.
    Terstegge K; Schörner W; Henkes H; Heye N; Hosten N; Lanksch WR
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):555-60. PubMed ID: 8197957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.
    Larson SR; Zhang X; Dumpit R; Coleman I; Lakely B; Roudier M; Higano CS; True LD; Lange PH; Montgomery B; Corey E; Nelson PS; Vessella RL; Morrissey C
    Prostate; 2013 Jun; 73(9):932-40. PubMed ID: 23334979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of bone-invasive, hyperostotic sphenoid wing meningiomas.
    Bikmaz K; Mrak R; Al-Mefty O
    J Neurosurg; 2007 Nov; 107(5):905-12. PubMed ID: 17977259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of meningioma and craniofacial fibrous dysplasia: a case series of clinicopathological study and literature review.
    Song X; Li Z
    Orphanet J Rare Dis; 2024 Jan; 19(1):30. PubMed ID: 38287340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma.
    Yokogami K; Watanabe T; Yamashita S; Mizuguchi A; Takeshima H
    J Neurooncol; 2024 May; 167(3):455-465. PubMed ID: 38446374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic AKT1 mutations cause meningiomas colocalizing with a characteristic pattern of cranial hyperostosis.
    Keppler-Noreuil KM; Baker EH; Sapp JC; Lindhurst MJ; Biesecker LG
    Am J Med Genet A; 2016 Oct; 170(10):2605-10. PubMed ID: 27550858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protruding Meningioma of the Forehead With Extensive Hyperostosis Mimicking Skull Osteoma.
    Seo DH; Shin JY; Roh SG; Chang SC; Lee NH
    J Craniofac Surg; 2020 Sep; 31(6):e542-e544. PubMed ID: 32371685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression of MIR17HG Protein as a Potential Therapeutic Target in Meningioma.
    Evran S; Baran O; Kayhan A; Katar S; Akkaya E; Cevik S; Kaya M; Sonmez D; Serin H; Kaynar MY
    World Neurosurg; 2020 May; 137():e554-e563. PubMed ID: 32068173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Co-expression of human bone morphogenetic protein-2 and osteoprotegerin in myoblast C2C12].
    Liu JZ; Hu YY; Ji ZL
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jan; 17(1):1-4. PubMed ID: 12916296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.